Elevai Biosciences, a Subsidiary of Elevai Labs (ELAB), Expands Patent Portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil prices ease as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: ELAB) | Delayed: 3.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $ | |||
| Open | $3.05 | 52 Week Low | $ | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $3.05 | EPS | $ | |||
| Volume | 776 | |||||
